Pharmacological treatments for substance use disorders.
Bailey
Katharine P
KP
High Watch Farm, Kent, Connecticut 06757, USA. katharine@snet.net
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000427:Alcohol Deterrents / Q000627:therapeutic use; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D002047:Buprenorphine / Q000627:therapeutic use; D004221:Disulfiram / Q000627:therapeutic use; D006801:Humans; D008691:Methadone / Q000627:therapeutic use; D009271:Naltrexone / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use; D009294:Narcotics / Q000627:therapeutic use; D009446:Neurobiology / Q000379:methods / Q000639:trends; D009480:Neuropharmacology / Q000379:methods / Q000639:trends; D011600:Psychopharmacology / Q000379:methods / Q000639:trends; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy* / Q000517:prevention & control; D019966:Substance-Related Disorders / Q000188:drug therapy* / Q000517:prevention & control
D000319:Adrenergic beta-Antagonists; D000427:Alcohol Deterrents; D014151:Anti-Anxiety Agents; D009292:Narcotic Antagonists; D009294:Narcotics; D001569:Benzodiazepines; D002047:Buprenorphine; D009271:Naltrexone; D004221:Disulfiram; D008691:Methadone